A patent titled "Pharmaceutical Composition Comprising Phenyl Piperazine Derivatives as Serotonin Reuptake Inhibitors" (Patent number -IN227963) was granted to
The Plaintiff alleged that the defendants manufactured and exported substantial quantities of generic version of VORTIOXETINE to
The defendants argued that the drug was not used in
Excerpts from the order:
Learned counsel for the defendants states that the defendants are not using the product in
Considering the averments in the plaint as also the documents filed therewith, this Court finds that the plaintiffs have made out a prima facie case in their favour and in case no ex-parte ad-interim injunction is granted, the plaintiffs would suffer an irreparable loss. The balance of convenience also lies in favour of the plaintiffs and against the defendants. Consequently, an ad-interim injunction is granted in favour of the plaintiffs and against the defendants in terms of prayer (i) and (ii) of para 23 of IA 12589/220 till the next date of hearing before this Court.
We hope this article was a useful read.
Please feel free check our services page to find out if we can cater to your requirements. You can also contact us to explore the option of working together.
Best regards - Team InvnTree
This work is licensed under a Creative Commons Attribution-Non Commercial 3.0 Unported License
Originally published
The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.
Ms
#399, 15th Cross, 5th Main
Sector-6, HSR Layout
Tel: 8039467555
Fax: 8039467555
E-mail: Hemanth@invntree.com
URL: www.invntree.com
© Mondaq Ltd, 2021 - Tel. +44 (0)20 8544 8300 - http://www.mondaq.com, source